The International Consortium of Investigative Journalists (ICIJ) with news organisations in 36 countries, including The Indian Express in India, has put under scrutiny effectively every medical device that goes into the human body. The result is Implant Files – and the findings are startling.
Johnson & Johnson has claimed that there are no patients with adverse reports in India. As reported today, The Indian Express tracked down down eight patients, five men and three women, who had the Pinnacle implanted.
Investigating the patients' records paints a story of suffering, neglect and indifference. Of them hitting a wall when it comes to seeking justice even as they fight debilitating pain, organ damage, pseudo-tumours, the toxic effects of excess cobalt-chromium in the blood.
The Indian Express investigation, conducted in association with The International Consortium of Investigative Journalists (ICIJ), found how the first Bill to regulate medical devices was drafted 12 years ago but was still not enacted.
The investigation found that global pharma majors have been pushing medical devices — from coronary stents and pacemakers to breast and knee implants — into markets via a dubious nexus with hospitals and doctors.
The Indian Express-ICIJ investigation has exposed the fault lines in the Indian healthcare system. The onus of action is on government because it is the single agency which can regulate both the implant manufacturers and the physicians.
The council was set up on December 7, days after The Indian Express published the Implant Files, a series of investigative reports on the big, medical bazaar where devices are advertised, sold, and surgically implanted across the world under regulatory systems riddled with holes.
This week we look at the importance of the Kartarpur corridor between India and Pakistan, why you should pay attention to the revelations from Implant Files and what the Maratha reservation could lead to.
The Indian Express-ICIJ investigation finds that at least 57 medical devices, many used in critical care, were being sold in India when the US Food and Drug Administration (FDA) clamped down on them for a range of faults over the last two years.
No one is checking the implants for safety; technicians often double up as surgeons; shame and stigma prevent patients from reporting the gruesome aftermath of what has gone wrong, an investigation by The Indian Express has found.